arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BAXTER INTERNATIONAL INC

BAX
$27.54 ▲ +0.54 (+2.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

BAXTER INTERNATIONAL INC faces fundamental challenges with weakness in Profit Margin (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $14.1B
Dividend Yield 1.89%
Revenue Growth 5.7%
Op. Margin -2.7%
ROIC -3.5%
FCF / Share $1.65
Trailing P/E
Price / Book 2.3x
FCF Yield 6.0%
Debt / Equity 1.54
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$11.24B
↑ +5.7%
Net Income Profit after all expenses
$-957.00M
↓ -47.5%
Operating Margin Operating profit as % of sales
-2.7%
↓ -2181.0% 23th
FCF / Share Free cash flow per share
$1.65
↓ -17.6%
Long-Term Debt Long-term obligations
$9.44B
↓ -28.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
31
Returns
30
Financial Health
31
Cash Quality
11

Dividend History

Dividend / share · sourced from SEC filings
$0.52 Latest / share
-50.0% YoY
-11.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 75 quarters